Jam Piper Jam
Truth Seeker
Nearly 100, LSD's Father Ponders His 'Problem Child'
By CRAIG S. SMITH
Published: January 7, 2006
BURG, Switzerland
ALBERT Hofmann, the father of LSD, walked slowly across the small corner office of his modernist home on a grassy Alpine hilltop here, hoping to show a visitor the vista that sweeps before him on clear days. But outside there was only a white blanket of fog hanging just beyond the crest of the hill. He picked up a photograph of the view on his desk instead, left there perhaps to convince visitors of what really lies beyond the windowpane.
Mr. Hofmann will turn 100 on Wednesday, a milestone to be marked by a symposium in nearby Basel on the chemical compound that he discovered and that famously unlocked the Blakean doors of perception, altering consciousnesses around the world. As the years accumulate behind him, Mr. Hofmann's conversation turns ever more insistently around one theme: man's oneness with nature and the dangers of an increasing inattention to that fact.
Rounding a century, Mr. Hofmann is physically reduced but mentally clear. He is prone to digressions, ambling with pleasure through memories of his boyhood, but his bright eyes flash with the recollection of a mystical experience he had on a forest path more than 90 years ago in the hills above Baden, Switzerland. The experience left him longing for a similar glimpse of what he calls "a miraculous, powerful, unfathomable reality."
MR. HOFMANN studied chemistry and took a job with the Swiss pharmaceutical company Sandoz Laboratories, because it had started a program to identify and synthesize the active compounds of medically important plants. He soon began work on the poisonous ergot fungus that grows in grains of rye. Midwives had used it for centuries to precipitate childbirths, but chemists had never succeeded in isolating the chemical that produced the pharmacological effect. Finally, chemists in the United States identified the active component as lysergic acid, and Mr. Hofmann began combining other molecules with the unstable chemical in search of pharmacologically useful compounds.
read
By CRAIG S. SMITH
Published: January 7, 2006
BURG, Switzerland
ALBERT Hofmann, the father of LSD, walked slowly across the small corner office of his modernist home on a grassy Alpine hilltop here, hoping to show a visitor the vista that sweeps before him on clear days. But outside there was only a white blanket of fog hanging just beyond the crest of the hill. He picked up a photograph of the view on his desk instead, left there perhaps to convince visitors of what really lies beyond the windowpane.
Mr. Hofmann will turn 100 on Wednesday, a milestone to be marked by a symposium in nearby Basel on the chemical compound that he discovered and that famously unlocked the Blakean doors of perception, altering consciousnesses around the world. As the years accumulate behind him, Mr. Hofmann's conversation turns ever more insistently around one theme: man's oneness with nature and the dangers of an increasing inattention to that fact.
Rounding a century, Mr. Hofmann is physically reduced but mentally clear. He is prone to digressions, ambling with pleasure through memories of his boyhood, but his bright eyes flash with the recollection of a mystical experience he had on a forest path more than 90 years ago in the hills above Baden, Switzerland. The experience left him longing for a similar glimpse of what he calls "a miraculous, powerful, unfathomable reality."
MR. HOFMANN studied chemistry and took a job with the Swiss pharmaceutical company Sandoz Laboratories, because it had started a program to identify and synthesize the active compounds of medically important plants. He soon began work on the poisonous ergot fungus that grows in grains of rye. Midwives had used it for centuries to precipitate childbirths, but chemists had never succeeded in isolating the chemical that produced the pharmacological effect. Finally, chemists in the United States identified the active component as lysergic acid, and Mr. Hofmann began combining other molecules with the unstable chemical in search of pharmacologically useful compounds.
read